MISSISSAUGA, ON, Nov. 10, 2020 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen test ...
Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...
BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...
Peer-Reviewed Study Suggests BD Antigen Test Likely to Be More Selective at Detecting Patients Who Are Shedding Infectious SARS-CoV-2 Virus FRANKLIN LAKES, N.J., Jan. 25, 2021 /PRNewswire/ -- BD ...
BD, a Franklin Lakes, N.J.-based medical technology company, recently unveiled the BD Veritor Plus System, a wireless diagnostic device that can detect influenza A and B, respiratory syncytial virus ...
Becton Dickinson ($BDX) is rolling out a next-generation diagnostic device that can quickly detect certain diseases including the flu. The company’s move comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback